Page last updated: 2024-09-05

lenalidomide and glycyrrhizic acid

lenalidomide has been researched along with glycyrrhizic acid in 1 studies

Compound Research Comparison

Studies
(lenalidomide)
Trials
(lenalidomide)
Recent Studies (post-2010)
(lenalidomide)
Studies
(glycyrrhizic acid)
Trials
(glycyrrhizic acid)
Recent Studies (post-2010) (glycyrrhizic acid)
3,5327252,8502,079701,068

Protein Interaction Comparison

ProteinTaxonomylenalidomide (IC50)glycyrrhizic acid (IC50)
Corticosteroid 11-beta-dehydrogenase isozyme 1Homo sapiens (human)0.0115
Corticosteroid 11-beta-dehydrogenase isozyme 1Mus musculus (house mouse)0.0135
Corticosteroid 11-beta-dehydrogenase isozyme 2Homo sapiens (human)0.0007

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, Q; Gong, Z; Jiao, F; Lv, J; Pei, M; Shi, C; Wang, L; Wang, Y; Zhang, H1

Other Studies

1 other study(ies) available for lenalidomide and glycyrrhizic acid

ArticleYear
TNF-α/HMGB1 inflammation signalling pathway regulates pyroptosis during liver failure and acute kidney injury.
    Cell proliferation, 2020, Volume: 53, Issue:6

    Topics: Acute Kidney Injury; Animals; Cell Differentiation; Glycyrrhizic Acid; HMGB1 Protein; Humans; Inflammation; Lenalidomide; Liver Failure, Acute; Macrophages; Male; Mice, Inbred C57BL; Polymorphism, Single Nucleotide; Pyroptosis; Signal Transduction; THP-1 Cells; Tumor Necrosis Factor-alpha

2020